Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China · Delayed Price · Currency is CNY 18.89
-0.11 (-0.58%)
Sep 24, 2026, 9:25 AM CST
SHA:688670 Market Cap
SHA:688670 has a market cap or net worth of 2.33 billion as of September 23, 2026. Its market cap has increased by 24.77% in one year.
Market Cap
2.33B
Enterprise Value
2.26B
Revenue
110.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.89
ChartMarket Cap Chart
Since August 2, 2021, SHA:688670's market cap has decreased from 7.30B to 2.33B, a decrease of -68.10%. That is a compound annual growth rate of -19.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 2.33B | -6.62% |
| Dec 31, 2025 | 2.49B | 66.91% |
| Dec 31, 2024 | 1.49B | -57.41% |
| Dec 29, 2023 | 3.51B | -7.32% |
| Dec 30, 2022 | 3.78B | -43.20% |
| Dec 31, 2021 | 6.66B | -8.72% |
| Aug 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guangdong VTR Bio-Tech | 2.79B |
| Zhejiang East Asia Pharmaceutical | 2.78B |
| Yantai Zhenghai Biotechnology | 2.77B |
| Shanghai Universal Biotech | 2.74B |
| Shenzhen Bioeasy Biotechnology | 2.68B |
| Shandong Sito Bio-technology | 2.62B |
| Jiangsu CoWin Biotech | 2.62B |
| Suzhou Fushilai Pharmaceutical | 2.40B |